Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department.
COVID 19 pandemic
gynecologic oncology
patient centered clinical pathway
surgical activity
surgical oncology
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
13
01
2021
accepted:
23
02
2021
entrez:
10
5
2021
pubmed:
11
5
2021
medline:
11
5
2021
Statut:
epublish
Résumé
We describe and analyze a "care as usual" strategy of a French Comprehensive Cancer Center during the COVID-19 pandemic to manage surgical patients with gynecological cancer. We conducted a retrospective analysis evaluating the surgical activity in our gynecologic oncology department between January 21 and May 12, 2020. We compared the surgical activity and surgical and oncologic outcomes during the pre-lockdown period and the pandemic period. The main objective was to evaluate the impact of the COVID-19 pandemic on surgical activity. The secondary objectives were to analyze the surgical and the oncologic outcomes. We compared the surgical activity during the 8 weeks after the national lockdown (85 procedures) to the surgical activity in the 8 weeks preceding the lockdown (127 procedures). We observed a 33% decrease in activity between the two periods. The clinical and epidemiologic characteristics were similar between the two periods. There were no differences between the surgical approaches (
Identifiants
pubmed: 33968755
doi: 10.3389/fonc.2021.653009
pmc: PMC8097084
doi:
Types de publication
Journal Article
Langues
eng
Pagination
653009Informations de copyright
Copyright © 2021 Blache, El Hajj, Jauffret, Houvenaeghel, Sabiani, Barrou, Masquin, Le Saout, Mokart, Faucher and Lambaudie.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Ann Surg. 2020 Jul;272(1):e5-e6
pubmed: 32221118
BMC Surg. 2017 Dec 28;17(1):136
pubmed: 29282059
Singapore Med J. 2020 Jul;61(7):378-380
pubmed: 32241064
N Engl J Med. 2003 Nov 27;349(22):2117-27
pubmed: 14645640
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
J Gynecol Obstet Hum Reprod. 2020 Jun;49(6):101729
pubmed: 32247066
J Surg Oncol. 2020 Aug;122(2):122-123
pubmed: 32476155
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Bull Cancer. 2019 Apr;106(4):354-370
pubmed: 30850152
J Natl Compr Canc Netw. 2020 Mar 20;:1-4
pubmed: 32197238
Int J Gynecol Cancer. 2020 Sep;30(9):1424-1433
pubmed: 32576608
J Clin Oncol. 2021 Jan 1;39(1):66-78
pubmed: 33021869
Gynecol Oncol. 2010 Sep;118(3):262-7
pubmed: 20573392
Gynecol Oncol. 2016 May;141(2):371-378
pubmed: 26906066
Eur J Surg Oncol. 2020 Mar;46(3):455-461
pubmed: 31806516
Int J Gynecol Cancer. 2020 May;30(5):561-563
pubmed: 32221023
JAMA Surg. 2019 Jun 1;154(6):530-538
pubmed: 30810740
Oncologist. 2020 Jun;25(6):e982-e985
pubmed: 32259322
Obstet Gynecol. 2006 Jan;107(1):77-85
pubmed: 16394043
Gynecol Oncol. 2020 Aug;158(2):236-243
pubmed: 32532460
Int J Gynecol Cancer. 2020 Jun;30(6):728-729
pubmed: 32354796
J Surg Oncol. 2014 Aug;110(2):107-14
pubmed: 24846705
Br J Surg. 2014 Feb;101(3):172-88
pubmed: 24469618
Chest. 2020 Jul;158(1):106-116
pubmed: 32275978